144
Participants
Start Date
May 31, 2010
Primary Completion Date
November 30, 2012
Study Completion Date
February 28, 2014
Entecavir
Tablets, Oral, 1 mg, once daily, 96 weeks
Tenofovir
Tablets, Oral, 300 mg, once daily, 96 weeks
Local Institution, Berlin
Local Institution, Berlin
Local Institution, Hamburg
Local Institution, Milan
Local Institution, Hamburg
Local Institution, Hanover
Local Institution, Orléans
Local Institution, Valencia
Local Institution, Bagno A Ripoli (Fi)
Local Institution, Strasbourg
Local Institution, Heindelberg
Local Institution, Lyon
Local Institution, Bari
Local Institution, Foggia
Local Institution, Tübingen
Local Institution, München
Local Institution, Clichy
Local Institution, Amsterdam
Local Institution, Arnhem
Local Institution, Rotterdam
Local Institution, Kielce
Local Institution, Krakow
Local Institution, Lodz
Local Institution, Wroclaw
Local Institution, Bucharest
Local Institution, Burcuresti
Local Institution, Timișoara
Local Institution, Barcelona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY